Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 2, 2013, Pages 241-246

  Feng, Chen chen ^a   Wang, Pao hsun ^a   Ding, Qiang ^a   Guan, Ming ^a   Zhang, Yuan fang ^a   Jiang, Hao wen ^a   Wen, Hui ^a   Wu, Zhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Bladder tumor; Microvessel density; Pigment epithelium derived factor; Tumor necrosis factor

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CANCER; BLADDER PAPILLOMA; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVESSEL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR RECURRENCE; UROGENITAL TRACT TUMOR; UROTHELIUM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; EYE PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; SERPINS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84875255671     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.12.001     Document Type: Article

References (27)

1. Puzio-Kuter A.M., Castillo-Martin M., Kinkade C.W., et al. Inactivation of p53 and PTEN promotes invasive bladder cancer. Genes Dev 2009, 23:675-680.
2. Mitra A.P., Datar R.H., Cote R.J. Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification. J Clin Oncol 2006, 24:5552-5564.
3. Kwak C., Ku J.H., Park J.Y., et al. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 2004, 171:149-152.
4. Bochner B.H., Cote R.J., Weidner N., et al. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis. JNCI J Natl Cancer Inst 1995, 87:1603-1612.
5. Cai1 J., Parr C., Watkins G., et al. Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. J Cancer Res Clin Oncol 2010, 136:1719-1727.
6. Gao Y., Yao A., Zhang W., et al. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular cancer in nude mice. Oncogene 2010, 29:2784-2794.
7. Guan M., Jiang H., Xu C., et al. Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol Ther 2007, 6:419-425.
8. Yang J., Chen S., Huang X., et al. Growth suppression of cervical cancer by pigment epithelium-derived factor via anti-angiogenesis. Cancer Biol Ther 2010, 9:975-977.
9. Feng C., Ding Q., Zhang Y., et al. Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9. Int Urol Nephrol 2010, Epub ahead of print.
10. Szlosarek P., Charles K.A., Balkwill F.R. Tumor necrosis factor-α as a tumor promoter. Eur J Cancer 2006, 42:745-750.
11. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs 2004, 90-109. IARC Press, Lyon. J.N. Eble, G. Sauter, J.I. Epstein (Eds.).
12. Rosai E.J. Rosai and Ackerman's Surgical Pathology, Vol I 2004, 1317-1359. Elsevier, China. 9th ed.
13. Ioachim E., Michael M.C., Salmas M., et al. Thrombospondin-1 expression in urothelial cancer: prognostic significance and association with p53 alterations, tumor angiogenesis, and extracellular matrix components. BMC Cancer 2006, 6:140-147.
14. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast cancer and other solid tumors. Breast Cancer Res Treat 1995, 36:169-180.
15. Tombran-Tink J., Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 1989, 30:1700-1707.
16. Filleur S., Nelius T., de Riese W., et al. Characterization of PEDF: A multi-functional serpin family protein. J Cell Biochem 2009, 106:769-775.
17. Jimenez B., Volpert O.V. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 2001, 78:663-672.
18. Ren J.G., Jie C., Talbot C. How PEDF prevents angiogenesis: a hypothesized pathway. Med Hypotheses 2005, 64:74-78.
19. Zhang T., Guan M., Xu C., et al. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci 2007, 81:1256-1263.
20. Christian J.S., Zhang Y.B., Zhou J.F., et al. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg 2005, 40:236-243.
21. Ratner A., Clark W.R. Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis. J Immunol 1993, 150:4303-4314.
22. Jiang H., Stewart C.A., Fast D.J., et al. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J Immunol 1992, 149:2137-2146.
23. Havell E.A., Fiers W., North R.J. The anti-tumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988, 167:1067-1085.
24. Yoshida S., Ono M., Shono T., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor &;α-dependent angiogenesis. Mol Cell Biol 1997, 17:4015-4023.
25. Leber T.M., Balkwill F.R. Regulation of monocyte MMP-9 production by TNF-α and a tumor-derived soluble factor (MMPSF). Br J Cancer 1998, 78:724-732.
26. Zhang S.X., Wang J.J., Gao G., et al. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J 2006, 20:323-325.
27. Babjuk M., Oosterlinck W., Sylvester R., et al. Guidelines on TaT1 (non-muscle-invasive) bladder cancer. European Association of Urology Guidelines 2008, 3-21. European Association of Urology, Arnhem, The Netherlands.